Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4176442
Max Phase: Preclinical
Molecular Formula: C46H73BrN8O16S
Molecular Weight: 1106.10
Molecule Type: Small molecule
Associated Items:
ID: ALA4176442
Max Phase: Preclinical
Molecular Formula: C46H73BrN8O16S
Molecular Weight: 1106.10
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@@H](C)[C@H]1C(=O)N(C)[C@@H](Cc2ccc(OC)c(Br)c2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O[C@H](C)[C@H](NC(=O)[C@H](NC(=O)[C@H](O)COS(=O)(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]2CC[C@@H](O)N1C2=O
Standard InChI: InChI=1S/C46H73BrN8O16S/c1-10-24(5)36-46(65)71-26(7)37(53-42(61)35(23(3)4)51-41(60)32(56)22-70-72(66,67)68)43(62)49-29(14-12-13-19-48)39(58)50-30-16-18-34(57)55(44(30)63)38(25(6)11-2)45(64)54(8)31(40(59)52-36)21-27-15-17-33(69-9)28(47)20-27/h15,17,20,23-26,29-32,34-38,56-57H,10-14,16,18-19,21-22,48H2,1-9H3,(H,49,62)(H,50,58)(H,51,60)(H,52,59)(H,53,61)(H,66,67,68)/t24-,25+,26+,29-,30-,31-,32+,34+,35+,36-,37-,38-/m0/s1
Standard InChI Key: TYBGMNWFFZOLIN-FRYYNXATSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1106.10 | Molecular Weight (Monoisotopic): 1104.4049 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gallegos DA, Saurí J, Cohen RD, Wan X, Videau P, Vallota-Eastman AO, Shaala LA, Youssef DTA, Williamson RT, Martin GE, Philmus B, Sikora AE, Ishmael JE, McPhail KL.. (2018) Jizanpeptins, Cyanobacterial Protease Inhibitors from a Symploca sp. Cyanobacterium Collected in the Red Sea., 81 (6): [PMID:29808677] [10.1021/acs.jnatprod.8b00117] |
Source(1):